Smartphone AI Assistance for Prehospital ECG Interpretation
ECG-IA
AI & Prehospital ECG Analysis: A Randomized Controlled Trial of a Smartphone Large Language Model for Occlusion Myocardial Infarction Detection by Prehospital Providers
2 other identifiers
interventional
144
1 country
1
Brief Summary
Prehospital providers interpret 12-lead electrocardiograms (ECGs) under time pressure and without immediate expert support. Missed acute coronary occlusion - occlusion myocardial infarction (OMI) - delays reperfusion, while false positive interpretations trigger unnecessary catheterization laboratory activations. Multimodal large language models (LLMs) available on any smartphone can now analyze a photographed ECG, and prehospital providers have begun using them spontaneously. No randomized trial has evaluated whether this practice improves diagnostic performance. This randomized controlled trial compares the diagnostic performance of prehospital providers interpreting ECG clinical vignettes with and without mandatory assistance from a single, version-locked smartphone large language model. Participants - paramedics, emergency medical technicians, nurses and physicians practicing in prehospital care in French-speaking Switzerland - are randomized 1:1 on a dedicated digital platform and answer 14 clinical vignettes presented in individually randomized order. Each vignette is built around a real, anonymized 12-lead ECG obtained during routine clinical care. The primary outcome is the proportion of vignettes for which the participant correctly identifies the presence or absence of an OMI. Secondary outcomes are sensitivity, specificity, and the accuracy of the prehospital priority decision level.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 27, 2026
CompletedStudy Start
First participant enrolled
September 2, 2026
CompletedFirst Posted
Study publicly available on registry
September 9, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 30, 2026
September 9, 2026
September 1, 2026
3 months
August 27, 2026
September 4, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Proportion of vignettes with correct identification of occlusion myocardial infarction (OMI) status
For each of the 14 vignettes, the participant answers a binary question: "At this stage of care, is an OMI (acute coronary occlusion) likely? Yes / No". Responses are scored against a reference standard defined a priori, vignette by vignette, by the study cardiologist and locked before data collection. This reference standard is the answer expected of a prehospital provider at the point of care, anchored on coronary angiography wherever angiography is discriminant. For non-ischaemic mimics the expected answer depends on whether the acute presentation allows the condition to be distinguished from a coronary occlusion: it does not for the Takotsubo case (expected answer "yes"), whereas acute pericarditis is usually recognisable (expected answer "no"). This pre-specified departure from a purely angiographic standard is reported as such, and the analysis is repeated in a sensitivity analysis classifying all mimics as non-OMI. The outcome is the proportion of correctly classified vignettes
Single study session, approximately 90 minutes; 14 vignettes per participant
Secondary Outcomes (3)
Sensitivity of OMI detection
Single study session, approximately 90 minutes
Specificity of OMI detection
Single study session, approximately 90 minutes
Accuracy of the prehospital priority decision level
Single study session, approximately 90 minutes
Other Outcomes (5)
Diagnostic accuracy on the closed-list diagnosis question
Single study session, approximately 90 minutes
Self-reported confidence and calibration
Single study session, approximately 90 minutes
Self-reported influence of the AI on the final answer
Single study session, approximately 90 minutes
- +2 more other outcomes
Study Arms (2)
Control: unaided ECG interpretation
NO INTERVENTIONParticipants interpret each of the 14 ECG vignettes without any assistance. Smartphones are turned face down and out of reach for the duration of the session. No intervention is administered.
AI-assisted ECG interpretation
EXPERIMENTALParticipants must consult the study-imposed large language model for every vignette before submitting their answer. The platform locks the submit button until use of the tool is confirmed. Participants remain free not to follow the interpretation produced by the model and may base their final answer on their own clinical reasoning.
Interventions
The platform transmits the ECG image to a single large language model (OpenAI GPT-4o, API snapshot gpt-4o-2024-08-06), locked for the entire study, together with a standardised prompt identical for all participants and all vignettes: "I am on an urgent prehospital call with a patient who presents this ECG. Analyse it and tell me what you think." Participants cannot modify the prompt, ask follow-up questions or provide additional clinical context. The model version and system fingerprint returned by the API are recorded for every call. The model's interpretation is displayed within the vignette. Use of the tool is mandatory; adherence to its interpretation is not.
Eligibility Criteria
You may qualify if:
- Prehospital care provider practising in French-speaking Switzerland
- Any level of training: emergency medical technician, paramedic (ES), nurse (ES/HES) in prehospital emergency care, or prehospital emergency physician
- Electronic informed consent signed before randomization
You may not qualify if:
- Cardiologist
- Any person not practising in prehospital care
- Insufficient command of written French to answer the vignettes reliably
- Refusal to participate or withdrawal of consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Caserne des pompiers de Morat (Swiss French-speaking prehospital clinical research conference)
Murten/Morat, Canton of Fribourg, 3280, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Participants and investigators cannot be masked to allocation, since participants in the intervention arm knowingly use the AI tool. The statistician conducting the primary analysis is masked: groups are coded "Group 1" and "Group 2", and the allocation key is held solely by the principal investigator and released only after database lock and approval of the statistical analysis plan.
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Maître-adjoint (Lecturer and Deputy Head of School), Principal Investigator
Study Record Dates
First Submitted
August 27, 2026
First Posted
September 9, 2026
Study Start
September 2, 2026
Primary Completion (Estimated)
November 30, 2026
Study Completion (Estimated)
November 30, 2026
Last Updated
September 9, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
- Time Frame
- From the date of publication, with no end date.
- Access Criteria
- Open access, no restriction, no request procedure.
Fully anonymised individual participant data - responses to all vignettes, demographic variables and platform-generated technical variables - will be deposited in an open repository (Zenodo or OSF) at the time of publication, in accordance with FAIR principles. The ECG tracings themselves are excluded from this deposit: they originate from routine clinical care at the Geneva University Hospitals, which authorise their use for this study only and do not permit transmission to third parties. Requests concerning the tracings must be addressed to the Geneva University Hospitals.